192 related articles for article (PubMed ID: 8200601)
1. [Biotechnology vaccines--development of new disease prevention. Research progress of Biocine in Siena--HIV, herpes, Helicobacter].
Keil TU
Fortschr Med; 1994 Apr; 112(11):53-4. PubMed ID: 8200601
[No Abstract] [Full Text] [Related]
2. [Prospects for vaccine development against HIV infection].
Kurth R; Binninger D; Ennen J; Denner J; Hartung S; Norley S
Verh Dtsch Ges Inn Med; 1991; 97():394-402. PubMed ID: 1808921
[No Abstract] [Full Text] [Related]
3. Role of herd immunity in determining the effect of vaccines against sexually transmitted disease.
Garnett GP
J Infect Dis; 2005 Feb; 191 Suppl 1():S97-106. PubMed ID: 15627236
[TBL] [Abstract][Full Text] [Related]
4. Update on HIV vaccines.
Meldorf M; Corey L
STEP Perspect; 1997; 9(2):5-6, 8-9. PubMed ID: 11364929
[TBL] [Abstract][Full Text] [Related]
5. [Current vaccination strategies].
Dietz K
Internist (Berl); 1992 Sep; 33(9):575-80. PubMed ID: 1399392
[No Abstract] [Full Text] [Related]
6. Phase 1 clinical trials of the National Institutes of Health Vaccine Research Center HIV/AIDS candidate vaccines.
Robinson HL; Weinhold KJ
J Infect Dis; 2006 Dec; 194(12):1625-7. PubMed ID: 17109331
[No Abstract] [Full Text] [Related]
7. Thailand's Prime-Boost HIV Vaccine Phase III.
Trinvuthipong C
Science; 2004 Feb; 303(5660):954-5. PubMed ID: 14963308
[No Abstract] [Full Text] [Related]
8. Clinical research. A setback and an advance on the AIDS vaccine front.
Cohen J
Science; 2003 Apr; 300(5616):28-9. PubMed ID: 12677027
[No Abstract] [Full Text] [Related]
9. Challenge of chimpanzees immunized with a recombinant canarypox-HIV-1 virus.
Girard M; van der Ryst E; Barré-Sinoussi F; Nara P; Tartaglia J; Paoletti E; Blondeau C; Jennings M; Verrier F; Meignier B; Fultz PN
Virology; 1997 May; 232(1):98-104. PubMed ID: 9185593
[TBL] [Abstract][Full Text] [Related]
10. Policy rebuttal. HIV vaccine trial justified.
McNeil JG; Johnston MI; Birx DL; Tramont EC
Science; 2004 Feb; 303(5660):961. PubMed ID: 14963313
[No Abstract] [Full Text] [Related]
11. [Development of a vaccine against HIV: is this aim accomplishable?].
Wagner R; Asbach B
MMW Fortschr Med; 2013 Jun; 155 Suppl 1():36-9. PubMed ID: 23961653
[No Abstract] [Full Text] [Related]
12. Engineered human vaccines.
Sandhu JS
Crit Rev Biotechnol; 1994; 14(1):1-27. PubMed ID: 8187202
[TBL] [Abstract][Full Text] [Related]
13. Vaccines for classic sexually transmitted diseases.
Adimora AA; Sparling PF; Cohen MS
Infect Dis Clin North Am; 1994 Dec; 8(4):859-76. PubMed ID: 7890936
[TBL] [Abstract][Full Text] [Related]
14. Novel adjuvants and delivery systems for HIV vaccines.
O'Hagan DT; Lavelle E
AIDS; 2002; 16 Suppl 4():S115-24. PubMed ID: 12699008
[No Abstract] [Full Text] [Related]
15. Outwitting HIV: Minnesota researchers take on a clever virus.
Bell H
Minn Med; 2009 Oct; 92(10):22-6. PubMed ID: 19916268
[No Abstract] [Full Text] [Related]
16. HIV vaccine efficacy trials: towards the future of HIV prevention.
Kim D; Elizaga M; Duerr A
Infect Dis Clin North Am; 2007 Mar; 21(1):201-17, x. PubMed ID: 17502236
[TBL] [Abstract][Full Text] [Related]
17. Strategies of constructing recombinant vaccines.
Sałamaszyńska-Guz A; Klimuszko D
Pol J Vet Sci; 2009; 12(1):133-9. PubMed ID: 19459451
[TBL] [Abstract][Full Text] [Related]
18. [Vaccinations in secondary immune defects--indications, vaccination success and complications].
Belohradsky BH; Nissl L
Ergeb Inn Med Kinderheilkd; 1992; 60():241-331. PubMed ID: 1582403
[No Abstract] [Full Text] [Related]
19. HIV/AIDS. Hedged bet: an unusual AIDS vaccine trial.
Cohen J
Science; 2005 Aug; 309(5737):1003. PubMed ID: 16099960
[No Abstract] [Full Text] [Related]
20. [-Development of a mouse model for Helicobacter pylori infection in the human--progress toward vaccination against ulcer disease?-].
Gallwitz B; Schmidt WE
Z Gastroenterol; 1996 Mar; 34(3):202-4. PubMed ID: 8650975
[No Abstract] [Full Text] [Related]
[Next] [New Search]
